Annual Report 2017-2018 Category Publications Date 2016 - present Client CARB-X CARB-X A NON-PROFIT PARTNERSHIP WITH...
Date 2016 - present
A NON-PROFIT PARTNERSHIP WITH A CLEAR GOAL
CARB-X is dedicated to accelerating the development of antibacterial products to address the rising threat of drug resistance. Partners have generously contributed more than $500 million to invest in 2016-2021.
The CARB-X partnership is special in that each partner brings unique motivation, goals and perspective. Although our perspectives are diverse, our goal is the same: accelerate scientific research to combat drug-resistant bacterial infections and save lives.
Below is a banner…